Drug companies make millions on lifestyle potions. Is R&D on more vital therapies lagging?
A vial of bacteria capable of computation? Injectable cells that survey the bloodstream and produce drugs on demand? These ideas might not be as far-fetched as they sound.
For thousands of years, people have interacted through speech and gesture. Truly easy-to-use machines will do the same.
Alternatives to silicon-based computing are long shots. Knowing that, why do HP, Lucent and IBM spend time and money pursuing them? Their reasons may surprise you.
A DNA mismatch raises fears.
Bioengineers grow a circulatory system on silicon.
Here's a little secret: Although you may think you own the software that you have paid good money for, you don't.
Blue LEDs light up consumer market